Tag: Chemotherapy-Induced Myelosuppression Treatments Market

Chemotherapy-Induced Myelosuppression Treatments Market Trends And Drivers The Chemotherapy-Induced Myelosuppression (CIM) Treatments Market was valued at USD 3.5 billion in 2022 and is projected to reach USD 7.2 billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030. The rising prevalence of cancer globally, along with increasing chemotherapy treatments, has led to […]